Geron Announces Conference Call to Discuss Financial Results for the 2009 Third Quarter
Business Wire
Oct 27, 2009
Geron Corporation (NASDAQ:GERN) will announce its financial results for
the 2009 third quarter on Thursday, October 29, 2009, after the closing
of the equity market. Thomas B. Okarma, Ph.D., M.D., Geron’s president
and chief executive officer, and David L. Greenwood, Geron’s executive
vice president and chief financial officer, will host a conference call
for analysts and investors on Friday, October 30 at 8:00 a.m. Pacific
Time, 11:00 a.m. Eastern Time.
Participants can access the conference call live via telephone by
dialing 866-356-3093 (U.S.); 617-597-5381 (international). The passcode
is 61745709. A live audio-only webcast is also available through a link
that is posted on the Events page in the Investor Relations section of
Geron’s Web site at http://www.geron.com.
The audio Web broadcast of the conference call will be available for
replay through November 30, 2009.
Geron is developing first-in-class biopharmaceuticals for the treatment
of cancer and chronic degenerative diseases, including spinal cord
injury, heart failure and diabetes. The company is advancing an
anti-cancer drug and a cancer vaccine that target the enzyme telomerase
through multiple clinical trials in different cancers. For more
information, visit www.geron.com.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
